Becton, Dickinson and Company (BDX)
Automate Your Wheel Strategy on BDX
With Tiblio's Option Bot, you can configure your own wheel strategy including BDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BDX
- Rev/Share 76.1971
- Book/Share 88.5832
- PB 2.3311
- Debt/Equity 0.7555
- CurrentRatio 1.1133
- ROIC 0.0473
- MktCap 58938935738.0
- FreeCF/Share 9.3157
- PFCF 22.0745
- PE 35.2714
- Debt/Assets 0.3467
- DivYield 0.0202
- ROE 0.0663
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | BDX | Citigroup | -- | Buy | -- | $233 | Feb. 3, 2026 |
| Initiation | BDX | RBC Capital Mkts | -- | Sector Perform | -- | $211 | Sept. 25, 2025 |
| Downgrade | BDX | Citigroup | Buy | Neutral | -- | $185 | May 22, 2025 |
| Downgrade | BDX | Raymond James | Outperform | Market Perform | -- | -- | May 2, 2025 |
| Downgrade | BDX | Goldman | Buy | Neutral | -- | $192 | May 2, 2025 |
| Downgrade | BDX | Piper Sandler | Overweight | Neutral | -- | $185 | May 2, 2025 |
| Downgrade | BDX | William Blair | Outperform | Market Perform | -- | -- | May 1, 2025 |
| Downgrade | BDX | BofA Securities | Buy | Neutral | -- | $190 | May 1, 2025 |
| Downgrade | BDX | Wells Fargo | Overweight | Equal Weight | -- | -- | May 1, 2025 |
| Upgrade | BDX | Citigroup | Neutral | Buy | $255 | $275 | Oct. 1, 2024 |
News
Countdown to Becton Dickinson (BDX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Neutral
Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Read More
BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Neutral
BDX completes a pilot with Envetec showing polystyrene Petri dishes can be safely recycled into new medical-grade feedstock.
Read More
Earnings Preview: Becton Dickinson (BDX) Q1 Earnings Expected to Decline
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Negative
Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
10 Highest Rated Dividend Kings For Generations Of Income
Published: January 29, 2026 by: Seeking Alpha
Sentiment: Positive
My top 10 Dividend Kings list prioritizes reliability, dividend safety, and attractive valuation for long-term, generational income. Selection criteria include payout ratios under 70%, strong dividend safety/growth grades, and favorable Quant, SA, and Wall Street ratings. ABM Industries leads with a low 31% payout ratio, 2.5% yield, B- safety/growth, and an A- valuation grade despite a Hold Quant rating.
Read More
BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Positive
BD launches BD Research Cloud 7.0 with AI-powered Horizon Panel Maker, boosting automation, data intelligence and productivity in flow cytometry.
Read More
BDX vs. SAUHY: Which Stock Is the Better Value Option?
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
BD to Announce Financial Results for its First Quarter of Fiscal 2026
Published: January 27, 2026 by: PRNewsWire
Sentiment: Neutral
FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m.
Read More
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
Published: January 27, 2026 by: PRNewsWire
Sentiment: Neutral
Distribution date and closing date for spin-off and merger with Waters Corporation set for February 9, 2026 FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) ("BD" or the "Company") today announced that the Company's Board of Directors has set the close of business on February 5, 2026, as the record date for the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business to BD's shareholders.
Read More
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Published: January 27, 2026 by: PRNewsWire
Sentiment: Neutral
Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass., Jan. 27, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that, at the Company's Special Meeting of Shareholders (the "Special Meeting") held today, Waters shareholders overwhelmingly voted to approve the issuance of shares of Waters common stock to shareholders of Becton, Dickinson and Company (NYSE: BDX) ("BD") in connection with the proposed combination of BD's Biosciences & Diagnostic Solutions business with Waters.
Read More
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
BD and Ypsomed Expand Partnership to Target Growing Biologics Market
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.
Read More
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Positive
BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.
Read More
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026
Published: January 15, 2026 by: Benzinga
Sentiment: Positive
The U.S. Food and Drug Administration on Thursday granted 510(k) clearance for Becton, Dickinson and Company's (NYSE: BDX) new breast biopsy system.
Read More
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
Published: January 07, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK and NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Read More
Why The ‘Magnificent 7' Is Out In 2026 And These 3 Dividends Are ‘In'
Published: January 07, 2026 by: Forbes
Sentiment: Neutral
Ignore the doom-and-gloom “predictions” about 2026. There are plenty of gains—and growing dividends—to be had for us this year.
Read More
Best Dividend Aristocrats For January 2026
Published: December 31, 2025 by: Seeking Alpha
Sentiment: Positive
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
Read More
BD and Penn Institute Ink Collaboration to Advance Immunotherapy
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
BDX teams up with the Penn Institute for Immunology and Immune Health to launch a high-parameter immune profiling study.
Read More
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
Published: December 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners
Published: December 17, 2025 by: Forbes
Sentiment: Positive
Today I have a sweet dividend “double shot” for you: The first? A 2.8% payout set to grow thanks to AI—and take the stock price up with it.
Read More
BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe
Published: December 16, 2025 by: Zacks Investment Research
Sentiment: Positive
BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.
Read More
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
Published: December 05, 2025 by: Zacks Investment Research
Sentiment: Positive
BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.
Read More
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
Published: November 17, 2025 by: PRNewsWire
Sentiment: Neutral
FRANKLIN LAKES, N.J. , Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie" Huffines and Jacqueline "Jacky" Wright to its board of directors, effective Dec. 1, 2025.
Read More
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive
BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.
Read More
Becton, Dickinson and Company (BDX) Q4 2025 Earnings Call Transcript
Published: November 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Becton, Dickinson and Company ( BDX ) Q4 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Adam Reiffe Thomas Polen - President, CEO & Chairman Christopher DelOrefice - Executive VP & CFO Conference Call Participants Travis Steed - BofA Securities, Research Division Patrick Wood - Morgan Stanley, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Hello, and welcome to BD's Fourth Quarter and Full Year Fiscal 2025 Earnings Call. At the request of …
Read More
3 Undervalued Dividend Kings to Buy on the Dip Right Now
Published: November 06, 2025 by: 24/7 Wall Street
Sentiment: Positive
Dividend Kings are stocks that've had their dividend payouts raised for 50 consecutive years or more, such as Target (NYSE:TGT ), Becton Dickinson (NYSE:BDX ), and Hormel Foods (NYSE:HRL ).
Read More
BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.
Read More
Becton Dickinson (BDX) Reports Q4 Earnings: What Key Metrics Have to Say
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
3 Beaten-Down Dividend Aristocrats Ready to Rebound by 100%
Published: October 28, 2025 by: 24/7 Wall Street
Sentiment: Positive
Dividend Aristocrats are some of the best stocks to buy when they go on sale, as they're backed by companies on a solid footing.
Read More
About Becton, Dickinson and Company (BDX)
- IPO Date 1973-02-21
- Website https://www.bd.com
- Industry Medical - Instruments & Supplies
- CEO Thomas E. Polen Jr.
- Employees 70000